GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

Research

Photo for NASPAF-ICH

NASPAF-ICH

Official Title

Non-VKA Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation and Previous IntraCerebral Hemorrhage Study

Status

Ongoing

Overview

To determine the feasibility of a controlled trial examining the efficacy and safety of NOACs compared with aspirin for stroke prevention in patients with high-risk AF and previous intracerebral hemorrhage (ICH).

 

Study Design

Open-label, multicentre national phase II randomized pilot study

 

Primary Endpoint

Composite of ischemic stroke and recurrent ICH

 

Number of Patients

100

Number of Sites

10

Number of Countries

1

Study Period

2016-2018

Principal Investigator

Ashkan Shoamanesh

Program Manager

Jackie Bosch, Jessica Tyrwhitt

Research Coordinator

Jodi Miller